中國平安(02318.HK)人工智能輔助診療系統支援菲律賓疫情防控工作
中國平安(02318.HK)公布,旗下人工智能AskBob CDSS輔助診療系統,為菲律賓的新冠肺炎疫情診斷和治療提供支援。全資子公司平安智慧城市與菲律賓的新城太平洋投資全資子公司MPHTC達成合作。
在菲律賓,平安智慧城市和MPHTC提供分別針對消費者及醫院的網站。在消費者網站方面,用戶可以通過MPHTC推出的一站式健康與生活方式應用程式mWell填寫有關新冠肺炎的問卷。AskBob CDSS的診斷算法將評估患者的風險水平,並建議相應的處理方案。相關診斷結果可用於推薦患者前往哪一家醫院作進一步的檢測。mWell應用程式會將患者的資料和評估結果發送到醫院網站,供醫生作進一步查閱。而患者相關測試結果可由醫生自行輸入醫院網站,並即時同步至mWell,以協助用戶更有效管理其健康狀況。
中國平安開發的AskBob CDSS系統是一套「知識+數據」的人工智能臨床決策支持系統,支持3,000多種疾病的診斷,以及2,000多種疾病的治療,當中包括新冠肺炎。自2019年推出以來,該系統已獲中國10個省份28個城市,合共超過17,000多家醫療機構使用。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of this article is for reference only. It does not constitute an offer, solicitation, recommendation, opinion or guarantee of any securities, financial products or instruments.The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance.